Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Myron Levin

Concepts (856)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Herpes Zoster
106
2025
319
18.150
 Why?
Herpes Zoster Vaccine
66
2025
160
16.640
 Why?
Herpesvirus 3, Human
87
2025
336
12.330
 Why?
Chickenpox
24
2023
81
5.040
 Why?
Antibodies, Viral
66
2024
653
4.970
 Why?
Immunity, Cellular
36
2024
269
4.590
 Why?
Chickenpox Vaccine
27
2023
74
3.820
 Why?
Influenza Vaccines
18
2024
551
2.830
 Why?
Vaccines, Attenuated
32
2024
130
2.690
 Why?
Antiviral Agents
29
2026
747
2.430
 Why?
HIV Infections
38
2018
3017
2.430
 Why?
Neuralgia, Postherpetic
18
2019
40
2.410
 Why?
Immunocompromised Host
13
2019
203
2.380
 Why?
Adjuvants, Immunologic
17
2023
238
2.100
 Why?
Simplexvirus
24
2016
82
2.080
 Why?
Acyclovir
27
2016
95
2.020
 Why?
Herpes Simplex
17
2016
95
1.880
 Why?
Vaccination
33
2023
1467
1.770
 Why?
DNA, Viral
24
2018
366
1.720
 Why?
Trypanosoma cruzi
13
2007
40
1.670
 Why?
Papillomavirus Vaccines
13
2018
321
1.480
 Why?
Viral Envelope Proteins
6
2021
97
1.450
 Why?
Herpesvirus 1, Human
10
2016
81
1.440
 Why?
Pregnancy Complications, Infectious
16
2020
406
1.390
 Why?
Vaccines, Synthetic
16
2025
139
1.380
 Why?
Influenza, Human
13
2024
626
1.360
 Why?
Humans
295
2026
141197
1.350
 Why?
T-Lymphocytes
20
2019
2003
1.340
 Why?
Aged
93
2026
24576
1.310
 Why?
Antiretroviral Therapy, Highly Active
13
2017
285
1.310
 Why?
Immunologic Memory
12
2019
360
1.270
 Why?
Aged, 80 and over
47
2022
7856
1.270
 Why?
Immunization, Secondary
13
2017
88
1.250
 Why?
CD4-Positive T-Lymphocytes
13
2023
1110
1.210
 Why?
Antibodies, Protozoan
5
2007
39
1.140
 Why?
Papillomavirus Infections
9
2018
380
1.100
 Why?
Middle Aged
102
2026
34438
1.090
 Why?
Ribosomal Proteins
6
2006
92
1.050
 Why?
Double-Blind Method
33
2026
1983
1.030
 Why?
Chagas Disease
8
2007
44
1.020
 Why?
Female
157
2026
75522
1.010
 Why?
Protozoan Proteins
6
2006
87
1.000
 Why?
Male
140
2026
69789
0.970
 Why?
T-Lymphocyte Subsets
6
2019
415
0.950
 Why?
Vaccines, Inactivated
9
2023
68
0.890
 Why?
Receptors, Adrenergic, beta-1
4
2007
22
0.880
 Why?
Viral Vaccines
12
2014
107
0.880
 Why?
Incidence
22
2023
2794
0.860
 Why?
Herpesvirus 2, Human
6
2014
29
0.850
 Why?
Virus Latency
4
2014
80
0.820
 Why?
Interferon-gamma
18
2022
792
0.810
 Why?
Respiratory Syncytial Virus, Human
3
2019
76
0.800
 Why?
Immune Sera
4
2020
84
0.800
 Why?
CD8-Positive T-Lymphocytes
5
2018
918
0.780
 Why?
B-Lymphocytes
9
2021
858
0.780
 Why?
Pneumococcal Vaccines
3
2021
139
0.780
 Why?
Injections, Intramuscular
5
2022
131
0.770
 Why?
Enzyme-Linked Immunosorbent Assay
22
2021
855
0.770
 Why?
Influenza A Virus, H1N1 Subtype
6
2017
151
0.740
 Why?
Respiratory Syncytial Virus Vaccines
2
2019
38
0.730
 Why?
Age Factors
17
2021
3292
0.720
 Why?
Antibodies, Neutralizing
12
2023
305
0.720
 Why?
Drug Resistance, Viral
7
2009
120
0.710
 Why?
Rotavirus Infections
3
2017
39
0.710
 Why?
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
6
2017
15
0.710
 Why?
Influenza B virus
6
2012
44
0.670
 Why?
Anti-Retroviral Agents
5
2018
245
0.660
 Why?
Vaccination Coverage
2
2018
96
0.650
 Why?
Rotavirus Vaccines
2
2017
42
0.640
 Why?
Adenovirus Infections, Human
4
2015
15
0.630
 Why?
Infectious Disease Transmission, Vertical
7
2020
186
0.630
 Why?
Adult
77
2026
39181
0.620
 Why?
Down Syndrome
2
2023
506
0.620
 Why?
Clinical Trials as Topic
15
2019
1052
0.600
 Why?
Th1 Cells
3
2018
139
0.600
 Why?
Polymerase Chain Reaction
13
2019
1056
0.600
 Why?
Insurance Claim Review
1
2019
85
0.580
 Why?
HIV
4
2010
250
0.580
 Why?
AIDS-Related Opportunistic Infections
4
2015
128
0.580
 Why?
Cytomegalovirus Infections
4
2015
197
0.580
 Why?
Influenza A Virus, H3N2 Subtype
4
2017
46
0.570
 Why?
Child, Preschool
42
2024
11457
0.570
 Why?
Alphapapillomavirus
4
2016
39
0.570
 Why?
CD4 Lymphocyte Count
14
2017
284
0.570
 Why?
Antibody Formation
8
2023
298
0.560
 Why?
Immunoglobulin G
11
2021
900
0.550
 Why?
Dose-Response Relationship, Immunologic
3
2016
85
0.550
 Why?
Infant
31
2023
9818
0.540
 Why?
Virus Shedding
6
2017
48
0.540
 Why?
Child
59
2024
22310
0.530
 Why?
Health Expenditures
1
2019
193
0.520
 Why?
Pneumonia
1
2023
656
0.520
 Why?
Anti-HIV Agents
6
2015
859
0.520
 Why?
Herpesviridae Infections
4
2015
148
0.510
 Why?
Pain
6
2022
781
0.510
 Why?
Cytosine
3
2015
48
0.510
 Why?
Interleukin-2
7
2022
453
0.510
 Why?
Adolescent
53
2024
22007
0.510
 Why?
Infant, Premature
5
2020
597
0.500
 Why?
Antigens, Viral
21
2017
179
0.490
 Why?
Organophosphonates
2
2015
99
0.490
 Why?
Cytomegalovirus
7
2006
163
0.480
 Why?
Injections, Subcutaneous
1
2016
165
0.480
 Why?
Follow-Up Studies
22
2019
5200
0.470
 Why?
Enzyme-Linked Immunospot Assay
4
2018
37
0.470
 Why?
Guanine
14
2006
81
0.470
 Why?
Refrigeration
2
2018
12
0.460
 Why?
Polyomavirus Infections
1
2015
30
0.450
 Why?
Health Care Costs
1
2018
424
0.450
 Why?
Viral Load
12
2018
506
0.440
 Why?
Immunization
5
2014
406
0.440
 Why?
Immunity, Humoral
3
2021
117
0.440
 Why?
Skin Diseases
1
2016
147
0.440
 Why?
Oropharynx
1
2014
45
0.440
 Why?
Herpes Genitalis
7
2014
18
0.430
 Why?
Uterine Cervical Neoplasms
5
2016
287
0.430
 Why?
Blood
1
2014
113
0.430
 Why?
Infant, Newborn
28
2023
6275
0.410
 Why?
Immunogenicity, Vaccine
4
2022
34
0.400
 Why?
Monocytes
8
2025
579
0.400
 Why?
T-Lymphocytes, Regulatory
1
2016
393
0.400
 Why?
Vaccines
3
2018
406
0.390
 Why?
Herpes Labialis
3
2013
8
0.390
 Why?
Trigeminal Ganglion
2
2003
23
0.390
 Why?
Time Factors
20
2021
6956
0.390
 Why?
Placebos
8
2017
198
0.390
 Why?
Aging
10
2017
1893
0.370
 Why?
Post-Exposure Prophylaxis
2
2023
13
0.370
 Why?
Sensory Receptor Cells
1
2012
101
0.360
 Why?
Retrospective Studies
16
2023
16273
0.360
 Why?
Young Adult
24
2023
13673
0.360
 Why?
RNA, Viral
21
2018
693
0.360
 Why?
Communicable Diseases
1
2014
161
0.360
 Why?
United States
17
2023
15220
0.350
 Why?
Randomized Controlled Trials as Topic
7
2021
1556
0.340
 Why?
Quality of Life
7
2021
2999
0.330
 Why?
Human papillomavirus 18
5
2018
16
0.320
 Why?
Human papillomavirus 16
5
2018
32
0.320
 Why?
Glycoproteins
2
2023
356
0.320
 Why?
Databases, Factual
4
2019
1444
0.320
 Why?
Pregnancy
20
2020
7070
0.320
 Why?
Animals
42
2021
37663
0.320
 Why?
Induced Pluripotent Stem Cells
1
2012
265
0.310
 Why?
Chagas Cardiomyopathy
4
2007
24
0.310
 Why?
Cost-Benefit Analysis
4
2024
618
0.300
 Why?
Poverty
1
2013
530
0.300
 Why?
Vaccines, Subunit
5
2021
50
0.300
 Why?
Immune Reconstitution Inflammatory Syndrome
1
2009
19
0.300
 Why?
Frail Elderly
2
2020
129
0.300
 Why?
Risk Factors
20
2023
10438
0.300
 Why?
Treatment Outcome
19
2016
11120
0.290
 Why?
Varicella Zoster Virus Infection
2
2018
24
0.280
 Why?
Epitopes
4
2005
477
0.280
 Why?
Meningitis, Viral
3
1997
20
0.270
 Why?
Activities of Daily Living
3
2021
424
0.270
 Why?
Meningitis
1
2008
81
0.270
 Why?
Hemagglutination Inhibition Tests
7
2017
38
0.270
 Why?
Seasons
3
2023
546
0.260
 Why?
Autoantibodies
3
2007
1470
0.260
 Why?
Viral Plaque Assay
8
2012
34
0.260
 Why?
Viremia
5
2018
150
0.260
 Why?
Recurrence
14
2019
1110
0.260
 Why?
Research Design
2
2013
1143
0.260
 Why?
Cytokines
7
2018
2098
0.260
 Why?
Cells, Cultured
19
2012
4208
0.260
 Why?
Prospective Studies
25
2019
7739
0.250
 Why?
Neurons
6
2003
1619
0.250
 Why?
Immunocompetence
4
2019
44
0.240
 Why?
Respiratory Syncytial Virus Infections
3
2017
130
0.240
 Why?
Nucleic Acid Hybridization
11
2006
189
0.230
 Why?
Neoplasms
3
2016
2741
0.230
 Why?
Drug-Related Side Effects and Adverse Reactions
4
2017
256
0.230
 Why?
Sleep Wake Disorders
4
2013
306
0.230
 Why?
Virus Replication
12
2018
532
0.220
 Why?
Nucleosides
1
2004
26
0.220
 Why?
Cross Reactions
6
2014
133
0.220
 Why?
Cell Count
2
2005
326
0.220
 Why?
Intestines
2
2018
357
0.220
 Why?
Severity of Illness Index
14
2015
2892
0.220
 Why?
Vaccine Potency
3
2019
6
0.220
 Why?
Transforming Growth Factor beta1
1
2025
171
0.220
 Why?
Viral Proteins
5
2018
369
0.220
 Why?
Influenza A virus
5
2012
111
0.220
 Why?
Molecular Sequence Data
9
2006
2929
0.220
 Why?
Health Resources
2
2019
129
0.210
 Why?
Nonlinear Dynamics
1
2005
92
0.210
 Why?
Depressive Disorder, Major
4
2013
374
0.210
 Why?
Phosphoproteins
1
2006
338
0.210
 Why?
Interferons
9
1982
195
0.210
 Why?
Herpesvirus 4, Human
3
2014
165
0.210
 Why?
Cholecalciferol
1
2024
61
0.210
 Why?
Genetic Variation
1
2008
1000
0.200
 Why?
Neuralgia
4
2010
143
0.200
 Why?
Immunoassay
2
2017
113
0.200
 Why?
Long-Term Care
1
2024
110
0.200
 Why?
Antibody Affinity
2
2021
60
0.200
 Why?
Cricetinae
6
2007
301
0.200
 Why?
Enterovirus Infections
5
1995
172
0.200
 Why?
Encephalitis
2
1995
137
0.190
 Why?
Transforming Growth Factor beta
1
2025
497
0.190
 Why?
Ganglia, Spinal
2
1993
88
0.190
 Why?
Developing Countries
2
2016
317
0.190
 Why?
CHO Cells
3
2007
168
0.190
 Why?
Drug Combinations
2
2022
358
0.190
 Why?
Pain Measurement
8
2019
554
0.190
 Why?
Lymphocyte Activation
13
2015
1150
0.190
 Why?
Virus Activation
4
2010
86
0.180
 Why?
Recombinant Proteins
4
2018
1357
0.180
 Why?
Lymphocytosis
1
2021
11
0.180
 Why?
Papillomaviridae
3
2011
133
0.180
 Why?
Longitudinal Studies
8
2018
2902
0.180
 Why?
Mice
12
2021
18055
0.180
 Why?
Immunosenescence
1
2021
5
0.170
 Why?
Cell Separation
1
2002
317
0.170
 Why?
Herpes Simplex Virus Vaccines
2
2012
4
0.170
 Why?
Genes, Protozoan
1
2000
13
0.170
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2021
76
0.170
 Why?
Virology
1
2001
36
0.170
 Why?
Fetal Diseases
4
1991
181
0.170
 Why?
Fluorescent Antibody Technique
6
2016
386
0.170
 Why?
Intermediate Filament Proteins
1
2000
58
0.170
 Why?
Fibroblasts
10
2018
1020
0.170
 Why?
Case-Control Studies
5
2018
3588
0.170
 Why?
RNA Helicases
1
2000
31
0.170
 Why?
Cell Line
16
2018
2885
0.170
 Why?
Amino Acid Sequence
5
2006
2158
0.170
 Why?
Vitamin D
1
2024
397
0.170
 Why?
Immunoglobulin A
3
2017
214
0.160
 Why?
Terminal Repeat Sequences
1
2000
18
0.160
 Why?
Short Interspersed Nucleotide Elements
1
2000
11
0.160
 Why?
Health Services for the Aged
1
2001
73
0.160
 Why?
HIV-1
5
2018
895
0.160
 Why?
Enterovirus
3
1995
85
0.160
 Why?
Feces
3
2017
504
0.160
 Why?
Laboratories
1
2001
110
0.160
 Why?
Cohort Studies
10
2022
5799
0.160
 Why?
Antibodies, Monoclonal, Humanized
1
2026
852
0.160
 Why?
Carrier Proteins
2
2001
740
0.160
 Why?
Acquired Immunodeficiency Syndrome
2
1993
235
0.160
 Why?
Retroelements
1
2000
49
0.160
 Why?
Antidepressive Agents
2
2013
254
0.160
 Why?
Epitope Mapping
3
2005
61
0.160
 Why?
Immunoenzyme Techniques
3
2006
209
0.160
 Why?
Immunization, Passive
4
1994
90
0.160
 Why?
Leukocytes, Mononuclear
5
2010
573
0.160
 Why?
Base Sequence
10
2007
2180
0.150
 Why?
Dietary Supplements
1
2024
566
0.150
 Why?
Myocytes, Cardiac
1
2004
535
0.150
 Why?
Pneumococcal Infections
2
2013
110
0.150
 Why?
Immunization Schedule
3
2016
203
0.150
 Why?
Delivery of Health Care, Integrated
1
2022
289
0.150
 Why?
Hemophilia A
2
1993
143
0.150
 Why?
Myocardium
3
2001
928
0.150
 Why?
Heart Transplantation
2
2007
714
0.150
 Why?
Liver Transplantation
1
2006
766
0.150
 Why?
Cholera Toxin
1
2018
31
0.150
 Why?
Autophagosomes
1
2018
20
0.150
 Why?
Infant, Premature, Diseases
3
1995
107
0.140
 Why?
Microbial Sensitivity Tests
8
2005
370
0.140
 Why?
Age Distribution
3
2016
395
0.140
 Why?
Sex Distribution
3
2016
379
0.140
 Why?
Fatty Acid-Binding Proteins
1
2018
71
0.140
 Why?
Killer Cells, Natural
2
2025
469
0.140
 Why?
Viral Fusion Proteins
1
2017
19
0.140
 Why?
Lymphocytes
8
1998
398
0.140
 Why?
Drug Therapy, Combination
4
2016
1040
0.140
 Why?
Immune Evasion
1
2018
63
0.140
 Why?
Simian virus 40
11
1977
25
0.140
 Why?
Regression Analysis
2
2019
1020
0.140
 Why?
Genes, Viral
2
2006
92
0.140
 Why?
Lysosomes
1
2018
146
0.140
 Why?
Multivariate Analysis
2
2018
1490
0.140
 Why?
Clinical Trials, Phase II as Topic
1
2017
73
0.140
 Why?
Clinical Trials, Phase I as Topic
1
2017
51
0.140
 Why?
Protein Subunits
1
2018
232
0.140
 Why?
Lysosomal-Associated Membrane Protein 1
1
2017
6
0.140
 Why?
Disease Transmission, Infectious
1
2018
69
0.130
 Why?
Cryopreservation
1
2018
106
0.130
 Why?
Cell Division
5
2003
798
0.130
 Why?
Cost of Illness
5
2014
312
0.130
 Why?
Models, Biological
1
2005
1828
0.130
 Why?
Observational Studies as Topic
1
2017
123
0.130
 Why?
Adverse Drug Reaction Reporting Systems
1
2017
81
0.130
 Why?
Infectious Mononucleosis
2
1991
10
0.130
 Why?
Receptors, Muscarinic
1
1996
20
0.130
 Why?
Receptors, Adrenergic, beta-2
1
1996
33
0.130
 Why?
Antibodies, Bacterial
3
2013
146
0.130
 Why?
Infusions, Intravenous
2
2016
417
0.130
 Why?
Africa
1
2017
119
0.130
 Why?
Depression
3
2013
1483
0.130
 Why?
Foscarnet
3
2003
20
0.120
 Why?
Triatoma
2
2006
7
0.120
 Why?
Nelfinavir
1
2016
9
0.120
 Why?
Latex Fixation Tests
1
1996
4
0.120
 Why?
Erythema
1
2016
28
0.120
 Why?
Comorbidity
3
2019
1662
0.120
 Why?
Frailty
1
2019
173
0.120
 Why?
Lopinavir
1
2016
31
0.120
 Why?
Insect Vectors
2
2006
39
0.120
 Why?
Atazanavir Sulfate
1
2016
44
0.120
 Why?
Ribavirin
2
1994
82
0.120
 Why?
Peptide Fragments
3
2007
698
0.120
 Why?
HIV Protease Inhibitors
1
2016
68
0.120
 Why?
Autophagy
1
2018
287
0.120
 Why?
Ritonavir
1
2016
75
0.120
 Why?
Bone Marrow Transplantation
3
1990
294
0.120
 Why?
Dipeptides
1
2015
53
0.120
 Why?
Hospitalization
2
2023
2255
0.120
 Why?
Lymphocyte Subsets
1
2015
88
0.120
 Why?
BK Virus
1
2015
16
0.110
 Why?
Genotype
3
2008
1859
0.110
 Why?
Brain Stem
1
1995
96
0.110
 Why?
Programmed Cell Death 1 Receptor
1
2017
257
0.110
 Why?
TOR Serine-Threonine Kinases
1
2018
423
0.110
 Why?
Chronic Disease
6
2019
1816
0.110
 Why?
Host-Pathogen Interactions
1
2018
372
0.110
 Why?
Hematopoietic Stem Cell Transplantation
2
2015
668
0.110
 Why?
Data Interpretation, Statistical
3
2019
376
0.110
 Why?
Guatemala
1
2016
347
0.110
 Why?
Propylene Glycols
1
2015
28
0.110
 Why?
Antibodies, Monoclonal
1
2022
1448
0.110
 Why?
Medication Reconciliation
1
2015
31
0.110
 Why?
Global Health
1
2018
386
0.110
 Why?
Sphingosine
1
2015
45
0.110
 Why?
Reproducibility of Results
5
2013
3348
0.110
 Why?
Survival Rate
3
2016
1970
0.110
 Why?
Infant, Newborn, Diseases
1
2016
113
0.110
 Why?
Transfusion Reaction
1
1995
62
0.110
 Why?
COS Cells
2
2007
183
0.110
 Why?
Maus Elberfeld virus
2
1991
5
0.110
 Why?
Immunity, Mucosal
2
2012
96
0.110
 Why?
Respiratory Syncytial Viruses
4
1993
58
0.110
 Why?
Chlamydia trachomatis
2
1991
50
0.110
 Why?
Maternal-Fetal Exchange
3
1995
172
0.110
 Why?
Species Specificity
3
2006
583
0.110
 Why?
Hemagglutinins, Viral
1
1994
7
0.110
 Why?
Clinical Trials, Phase III as Topic
3
2021
106
0.110
 Why?
Histocompatibility Antigens Class I
1
1996
209
0.110
 Why?
Laryngeal Diseases
1
1994
30
0.110
 Why?
DNA-Directed DNA Polymerase
2
1992
47
0.110
 Why?
Lymphoma
1
2015
228
0.100
 Why?
Rats
4
2006
5629
0.100
 Why?
Autoantigens
1
1996
422
0.100
 Why?
Immunoglobulins, Intravenous
5
1995
128
0.100
 Why?
Needs Assessment
1
2016
382
0.100
 Why?
Zidovudine
2
2015
79
0.100
 Why?
Lamivudine
2
2015
65
0.100
 Why?
Controlled Clinical Trials as Topic
1
2013
28
0.100
 Why?
Placenta
2
1991
761
0.100
 Why?
Cross-Over Studies
2
2013
578
0.100
 Why?
Analgesics
3
2010
226
0.100
 Why?
Anti-Inflammatory Agents
3
2013
482
0.100
 Why?
Ethics, Research
1
2013
34
0.100
 Why?
Research Subjects
1
2013
43
0.100
 Why?
Health Status
2
2010
823
0.100
 Why?
Practice Guidelines as Topic
2
2017
1597
0.100
 Why?
RNA Probes
2
1991
13
0.100
 Why?
Mice, Inbred BALB C
3
2006
1274
0.100
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
1996
286
0.100
 Why?
Epitopes, T-Lymphocyte
1
2014
184
0.100
 Why?
Dose-Response Relationship, Drug
4
2026
2064
0.100
 Why?
Risk Assessment
4
2016
3490
0.100
 Why?
Measles Vaccine
1
2012
21
0.090
 Why?
Picornaviridae Infections
2
1990
51
0.090
 Why?
Autoimmune Diseases
1
1996
464
0.090
 Why?
Gene Expression Regulation, Viral
1
2012
99
0.090
 Why?
Drug Resistance, Microbial
4
2001
65
0.090
 Why?
Human papillomavirus 31
1
2011
1
0.090
 Why?
Ureaplasma urealyticum
1
1991
3
0.090
 Why?
Immunosuppressive Agents
3
2015
854
0.090
 Why?
Meningitis, Aseptic
1
1991
13
0.090
 Why?
Colorado
4
2018
4610
0.090
 Why?
Indoles
1
2015
429
0.090
 Why?
T-Lymphocytes, Cytotoxic
2
2011
174
0.090
 Why?
Flow Cytometry
5
2017
1197
0.090
 Why?
Efficiency
1
2012
100
0.090
 Why?
Chorioamnionitis
1
1991
43
0.090
 Why?
Linear Models
2
2010
857
0.090
 Why?
Insurance, Health
1
2014
299
0.090
 Why?
Mutation
5
2009
4013
0.090
 Why?
Cytotoxicity Tests, Immunologic
2
1996
38
0.090
 Why?
Gastroenteritis
2
1989
68
0.090
 Why?
Macrophages
3
2005
1560
0.090
 Why?
Neurogenesis
1
2012
154
0.090
 Why?
Neural Stem Cells
1
2012
161
0.080
 Why?
Drug Design
1
2012
168
0.080
 Why?
Sequence Alignment
2
2008
363
0.080
 Why?
Adjuvants, Pharmaceutic
2
2022
12
0.080
 Why?
Epidemiological Monitoring
3
2018
65
0.080
 Why?
Cervix Uteri
1
2010
53
0.080
 Why?
Exanthema
1
2011
81
0.080
 Why?
Serum
1
2010
60
0.080
 Why?
Electrocardiography
2
2005
618
0.080
 Why?
Sensitivity and Specificity
3
2009
1973
0.080
 Why?
Adenoviridae
9
2005
201
0.080
 Why?
Herpesviridae
2
1981
22
0.080
 Why?
Antidepressive Agents, Tricyclic
1
2010
30
0.080
 Why?
Heart Rate
2
2006
821
0.080
 Why?
Herpesvirus Vaccines
1
2010
4
0.080
 Why?
Health Services Accessibility
1
2018
1016
0.080
 Why?
Antigen-Presenting Cells
5
2010
159
0.080
 Why?
Immunoglobulin M
1
1991
287
0.080
 Why?
Enterovirus B, Human
2
1988
26
0.080
 Why?
Respiratory Tract Infections
1
1994
385
0.080
 Why?
Dermatomyositis
1
1989
23
0.080
 Why?
DNA, Kinetoplast
2
2006
2
0.080
 Why?
Medicaid
1
2014
451
0.080
 Why?
Poliovirus
2
2001
85
0.080
 Why?
Hepatitis B Vaccines
1
2009
43
0.080
 Why?
Receptors, Virus
2
2006
96
0.080
 Why?
Placenta Diseases
1
1989
19
0.080
 Why?
Pilot Projects
1
2015
1820
0.080
 Why?
Protozoan Infections
1
1989
11
0.080
 Why?
DNA Primers
2
2009
510
0.080
 Why?
Thymidine Kinase
4
2001
15
0.080
 Why?
Surveys and Questionnaires
7
2021
5929
0.080
 Why?
Drug Stability
1
2009
166
0.080
 Why?
Skin Diseases, Viral
1
2008
6
0.070
 Why?
Oligonucleotide Probes
1
1988
50
0.070
 Why?
Geriatrics
1
2010
93
0.070
 Why?
Vagina
1
2010
194
0.070
 Why?
Immunologic Deficiency Syndromes
2
1986
72
0.070
 Why?
Gene Expression
2
2006
1491
0.070
 Why?
Postoperative Complications
2
2000
2797
0.070
 Why?
Geriatric Assessment
1
2010
221
0.070
 Why?
Muscles
1
1989
333
0.070
 Why?
Interferon Type I
1
1989
141
0.070
 Why?
Administration, Intranasal
1
2008
92
0.070
 Why?
Kinetics
2
2010
1652
0.070
 Why?
In Vitro Techniques
6
2003
1093
0.070
 Why?
Hydrocortisone
1
2010
316
0.070
 Why?
Poisson Distribution
2
2005
77
0.070
 Why?
Picornaviridae
1
1988
20
0.070
 Why?
Enterocolitis, Pseudomembranous
1
1988
28
0.070
 Why?
Lipid A
2
2018
29
0.070
 Why?
Anticonvulsants
1
2010
225
0.070
 Why?
Pertussis Vaccine
1
2007
24
0.070
 Why?
Evidence-Based Practice
1
2010
236
0.070
 Why?
Immunosorbent Techniques
1
2007
19
0.070
 Why?
Quality-Adjusted Life Years
1
2007
113
0.070
 Why?
Spinal Cord
2
2001
373
0.070
 Why?
Prevalence
4
2018
2772
0.070
 Why?
Data Collection
1
2010
661
0.070
 Why?
Cricetulus
1
2007
111
0.070
 Why?
Acute Kidney Injury
1
2015
819
0.070
 Why?
Receptor, IGF Type 2
1
2006
5
0.060
 Why?
Inhibitory Concentration 50
1
2006
91
0.060
 Why?
Vero Cells
1
2006
87
0.060
 Why?
Pregnancy Outcome
1
2010
457
0.060
 Why?
Trypanosomatina
1
2006
1
0.060
 Why?
Opportunistic Infections
3
1993
45
0.060
 Why?
Veterans
1
2018
1514
0.060
 Why?
Heparitin Sulfate
1
2006
45
0.060
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
1996
1787
0.060
 Why?
Immunoglobulin Fragments
1
2006
12
0.060
 Why?
Animal Diseases
1
2006
8
0.060
 Why?
Neutralization Tests
5
2012
81
0.060
 Why?
Research
1
2010
455
0.060
 Why?
Public Health
1
2012
587
0.060
 Why?
NIH 3T3 Cells
1
2006
149
0.060
 Why?
Drug Administration Schedule
2
2021
771
0.060
 Why?
Administration, Topical
4
2013
150
0.060
 Why?
Cyclic AMP
1
2007
219
0.060
 Why?
Immunoglobulin Variable Region
1
2006
81
0.060
 Why?
Random Allocation
6
1992
367
0.060
 Why?
Trees
1
2006
70
0.060
 Why?
Kaplan-Meier Estimate
3
2016
909
0.060
 Why?
Meningococcal Vaccines
1
2006
64
0.060
 Why?
Nasopharyngeal Diseases
1
1985
5
0.060
 Why?
Pneumonia, Viral
2
1990
374
0.060
 Why?
Logistic Models
2
2010
2086
0.060
 Why?
Hybridization, Genetic
9
1974
78
0.060
 Why?
Bone Marrow
2
1984
302
0.060
 Why?
Sequence Analysis, DNA
3
2007
824
0.060
 Why?
Endocytosis
1
2006
175
0.060
 Why?
Motor Activity
1
2010
717
0.060
 Why?
GB virus C
1
2005
1
0.060
 Why?
Flaviviridae Infections
1
2005
2
0.060
 Why?
Proportional Hazards Models
1
2009
1261
0.060
 Why?
Hepatitis, Viral, Human
1
2005
22
0.060
 Why?
Antineoplastic Agents
2
2016
2166
0.060
 Why?
Predictive Value of Tests
3
2010
2070
0.060
 Why?
Hydrogen-Ion Concentration
1
2006
556
0.060
 Why?
HLA Antigens
3
1987
233
0.060
 Why?
Normal Distribution
1
2005
21
0.060
 Why?
Cell Differentiation
1
2012
2003
0.060
 Why?
Uterine Cervical Dysplasia
2
2016
45
0.060
 Why?
Evaluation Studies as Topic
3
1996
175
0.060
 Why?
Conservation of Natural Resources
1
2006
128
0.060
 Why?
Transfection
1
2007
943
0.060
 Why?
Organ Transplantation
1
2008
250
0.060
 Why?
Open Reading Frames
2
2007
132
0.060
 Why?
Autopsy
2
2001
98
0.060
 Why?
Blotting, Western
3
2015
1234
0.060
 Why?
Mammals
1
2006
287
0.050
 Why?
Neurons, Afferent
1
2005
101
0.050
 Why?
Risk
3
2016
904
0.050
 Why?
Receptors, Cholinergic
1
2004
40
0.050
 Why?
Disease Outbreaks
1
1988
420
0.050
 Why?
Macaca radiata
2
2001
16
0.050
 Why?
Cell Culture Techniques
1
2006
368
0.050
 Why?
Cell Adhesion Molecules
1
2005
179
0.050
 Why?
Receptors, Adrenergic, beta
1
2004
69
0.050
 Why?
Mental Health
1
2010
749
0.050
 Why?
Polymorphism, Restriction Fragment Length
1
2003
68
0.050
 Why?
Sex Factors
2
2003
2059
0.050
 Why?
Demography
2
2018
296
0.050
 Why?
Abdominal Neoplasms
1
2003
47
0.050
 Why?
Down-Regulation
1
2025
641
0.050
 Why?
Receptors, Cell Surface
1
2005
397
0.050
 Why?
Multicenter Studies as Topic
2
2001
338
0.050
 Why?
2-Aminopurine
2
2007
8
0.050
 Why?
RNA
2
1988
930
0.050
 Why?
Polymorphism, Single Nucleotide
2
2009
2134
0.050
 Why?
Pre-Exposure Prophylaxis
1
2026
239
0.050
 Why?
Membrane Glycoproteins
1
2005
501
0.050
 Why?
Adaptive Immunity
2
2017
173
0.050
 Why?
Biopsy
2
2000
1081
0.050
 Why?
Argentina
3
2006
28
0.050
 Why?
Neuroblastoma
1
2003
164
0.050
 Why?
Poliomyelitis
2
2001
37
0.050
 Why?
Dendritic Cells
1
2025
505
0.050
 Why?
Forecasting
3
2010
384
0.050
 Why?
Maltose-Binding Proteins
1
2001
13
0.050
 Why?
Hepatitis C
1
2004
250
0.040
 Why?
Cell Nucleus
3
1991
609
0.040
 Why?
Glutathione Transferase
1
2001
101
0.040
 Why?
Respirovirus Infections
2
1991
13
0.040
 Why?
Spondylarthropathies
1
2021
6
0.040
 Why?
Poliovirus Vaccine, Oral
1
2001
25
0.040
 Why?
Interspersed Repetitive Sequences
1
2000
5
0.040
 Why?
Alanine
1
2001
153
0.040
 Why?
Mutagenesis
1
2001
182
0.040
 Why?
Blotting, Southern
1
2000
75
0.040
 Why?
Expressed Sequence Tags
1
2000
42
0.040
 Why?
Peripheral Nerves
1
2001
71
0.040
 Why?
Fatal Outcome
1
2001
309
0.040
 Why?
Endocardium
1
2000
31
0.040
 Why?
Secondary Prevention
2
2013
241
0.040
 Why?
Cloning, Molecular
1
2001
533
0.040
 Why?
Blotting, Northern
1
2000
198
0.040
 Why?
Phosphorylation
2
2002
1768
0.040
 Why?
Genome, Viral
1
2002
223
0.040
 Why?
Virion
1
2001
113
0.040
 Why?
Sex Characteristics
2
2017
788
0.040
 Why?
DNA, Protozoan
1
2000
32
0.040
 Why?
Amino Acid Motifs
1
2000
225
0.040
 Why?
Consensus Sequence
1
2000
74
0.040
 Why?
DEAD-box RNA Helicases
1
2000
78
0.040
 Why?
Psoriasis
1
2021
110
0.040
 Why?
Canada
2
2012
428
0.040
 Why?
Amniotic Fluid
3
1991
79
0.040
 Why?
Autoimmunity
1
2005
908
0.040
 Why?
Immunity, Innate
1
2025
852
0.040
 Why?
Chromosome Mapping
1
2000
504
0.040
 Why?
Transcription, Genetic
5
2000
1487
0.040
 Why?
Sequence Homology, Amino Acid
1
2000
391
0.040
 Why?
Enterotoxins
2
1994
88
0.040
 Why?
Sleep
1
2006
877
0.040
 Why?
Recombinant Fusion Proteins
1
2001
672
0.040
 Why?
Rats, Sprague-Dawley
1
2004
2520
0.040
 Why?
Saponins
1
2018
9
0.040
 Why?
Hematopoietic Stem Cells
1
1982
411
0.040
 Why?
Saliva
2
2010
245
0.040
 Why?
Haptoglobins
1
2018
56
0.040
 Why?
Seroconversion
1
2018
46
0.040
 Why?
Encephalitis, Viral
1
1998
45
0.030
 Why?
Drug Compounding
1
2018
104
0.030
 Why?
Protein Precursors
1
2018
133
0.030
 Why?
Celiac Disease
1
2021
295
0.030
 Why?
Immunologic Techniques
2
1994
39
0.030
 Why?
Glucosides
1
2017
49
0.030
 Why?
Inositol Phosphates
1
2017
22
0.030
 Why?
Sterols
1
2017
20
0.030
 Why?
Botswana
1
2017
11
0.030
 Why?
Cell Transformation, Neoplastic
5
1977
333
0.030
 Why?
Health Surveys
1
2019
505
0.030
 Why?
International Cooperation
1
2018
203
0.030
 Why?
Internationality
1
2018
158
0.030
 Why?
Zimbabwe
1
2017
61
0.030
 Why?
Graft Rejection
1
2000
544
0.030
 Why?
Chemotaxis
1
2017
133
0.030
 Why?
Zambia
1
2017
57
0.030
 Why?
Tanzania
1
2017
59
0.030
 Why?
Antigens, Bacterial
1
2017
125
0.030
 Why?
Bisoprolol
1
1996
2
0.030
 Why?
Plasma
1
2018
220
0.030
 Why?
Recovery of Function
1
2021
678
0.030
 Why?
Patient Safety
1
2020
335
0.030
 Why?
Propanolamines
1
1996
39
0.030
 Why?
Cerebrospinal Fluid
2
1993
92
0.030
 Why?
Immune Tolerance
4
1998
368
0.030
 Why?
Acute Disease
2
2011
1008
0.030
 Why?
Biomarkers
2
2018
4175
0.030
 Why?
Leukemia, Lymphoid
2
1986
27
0.030
 Why?
Sinusitis
1
1999
239
0.030
 Why?
False Negative Reactions
1
1996
61
0.030
 Why?
Public Health Surveillance
1
2016
84
0.030
 Why?
False Positive Reactions
1
1996
125
0.030
 Why?
Amniocentesis
2
1991
20
0.030
 Why?
Inhibitor of Apoptosis Proteins
1
2015
49
0.030
 Why?
AIDS Dementia Complex
1
2015
52
0.030
 Why?
Half-Life
2
1992
146
0.030
 Why?
Nevirapine
1
2015
18
0.030
 Why?
Analysis of Variance
2
2011
1320
0.030
 Why?
Cross-Sectional Studies
4
2011
5636
0.030
 Why?
Depressive Disorder
1
1998
394
0.030
 Why?
Adrenergic beta-Antagonists
1
1996
228
0.030
 Why?
Nausea
1
2015
111
0.030
 Why?
Chi-Square Distribution
2
2013
521
0.030
 Why?
Vomiting
1
2015
129
0.030
 Why?
Area Under Curve
1
2015
324
0.030
 Why?
Gene Regulatory Networks
1
2017
313
0.030
 Why?
Bromodeoxyuridine
2
2007
80
0.030
 Why?
Fingolimod Hydrochloride
1
2015
43
0.030
 Why?
Product Surveillance, Postmarketing
1
2015
68
0.030
 Why?
Disease Susceptibility
1
1996
352
0.030
 Why?
Headache
1
2015
148
0.030
 Why?
Breast Feeding
1
2018
444
0.030
 Why?
Neutropenia
1
2015
157
0.030
 Why?
Belgium
1
2014
12
0.030
 Why?
Vaccines, Virus-Like Particle
1
2014
3
0.030
 Why?
HLA-A2 Antigen
1
2014
49
0.030
 Why?
Rubella
1
1974
21
0.030
 Why?
Bacterial Proteins
1
2000
911
0.030
 Why?
Metabolic Diseases
1
2015
114
0.030
 Why?
Culture Media
2
1984
163
0.030
 Why?
Tetanus Toxoid
1
1994
37
0.030
 Why?
Immunoblotting
1
1994
310
0.030
 Why?
Probability
2
2005
309
0.030
 Why?
Hemagglutinin Glycoproteins, Influenza Virus
1
1994
25
0.030
 Why?
Drugs, Investigational
1
2014
32
0.030
 Why?
Anemia
1
2015
177
0.030
 Why?
Seroepidemiologic Studies
1
2014
166
0.030
 Why?
Statistics, Nonparametric
2
2004
434
0.030
 Why?
Phenotype
1
2002
3166
0.030
 Why?
Thrombocytopenia
1
2015
208
0.020
 Why?
Developed Countries
1
2013
39
0.020
 Why?
Mortality
1
2015
358
0.020
 Why?
Haplorhini
8
1974
53
0.020
 Why?
Human papillomavirus 6
1
2011
4
0.020
 Why?
Drug Tolerance
1
1992
105
0.020
 Why?
Ureaplasma Infections
1
1991
3
0.020
 Why?
Mycoplasma Infections
1
1991
16
0.020
 Why?
Arthritis, Rheumatoid
1
2021
1176
0.020
 Why?
Genetics, Microbial
3
1971
10
0.020
 Why?
Skin
2
1989
765
0.020
 Why?
Safety
1
1994
356
0.020
 Why?
gamma-Globulins
1
1991
18
0.020
 Why?
Genitalia, Female
1
2012
41
0.020
 Why?
Antibodies, Heterophile
1
1991
13
0.020
 Why?
Epstein-Barr Virus Nuclear Antigens
1
1991
12
0.020
 Why?
Phylogeny
2
2006
1018
0.020
 Why?
Metabolomics
1
2017
705
0.020
 Why?
Absenteeism
1
2012
52
0.020
 Why?
Consensus
1
2015
704
0.020
 Why?
Adenoviruses, Human
1
1991
27
0.020
 Why?
Adrenal Cortex Hormones
1
2015
501
0.020
 Why?
Early Detection of Cancer
1
2016
441
0.020
 Why?
Hospitals, University
1
1991
175
0.020
 Why?
Matched-Pair Analysis
1
2011
38
0.020
 Why?
Bodily Secretions
1
2010
2
0.020
 Why?
Inflammation
2
2017
2889
0.020
 Why?
North America
1
2012
306
0.020
 Why?
Paramyxoviridae Infections
1
1990
12
0.020
 Why?
Tritium
7
1974
72
0.020
 Why?
Europe
1
2012
410
0.020
 Why?
Diagnosis, Differential
3
2009
1498
0.020
 Why?
Chlamydia Infections
1
1991
80
0.020
 Why?
Schwann Cells
1
1990
34
0.020
 Why?
DNA
4
1988
1444
0.020
 Why?
Bacterial Infections
2
2001
245
0.020
 Why?
Antigens
2
1970
362
0.020
 Why?
Rhinovirus
1
1990
58
0.020
 Why?
Antigens, Surface
2
1987
156
0.020
 Why?
Serotyping
2
1988
33
0.020
 Why?
Cell Proliferation
1
2018
2504
0.020
 Why?
Health Planning Guidelines
1
2010
25
0.020
 Why?
Self Administration
1
2010
126
0.020
 Why?
Drug Resistance, Neoplasm
1
2015
830
0.020
 Why?
Gene Expression Profiling
1
2017
1764
0.020
 Why?
Gestational Age
2
1989
957
0.020
 Why?
Hepatitis B Antibodies
1
2009
9
0.020
 Why?
beta-Globins
1
2009
8
0.020
 Why?
Contraceptive Devices, Male
1
1989
1
0.020
 Why?
In Situ Hybridization
2
2001
320
0.020
 Why?
Subacute Sclerosing Panencephalitis
1
1989
6
0.020
 Why?
Spermatocidal Agents
1
1989
7
0.020
 Why?
Ribonucleosides
1
1989
6
0.020
 Why?
Reference Values
1
2011
805
0.020
 Why?
Physical Examination
1
2010
241
0.020
 Why?
Immunohistochemistry
1
1993
1737
0.020
 Why?
Thymidine
4
1980
60
0.020
 Why?
RNA, Antisense
1
1988
17
0.020
 Why?
Prenatal Exposure Delayed Effects
1
2016
662
0.020
 Why?
Nasal Mucosa
1
2009
106
0.020
 Why?
Reference Standards
1
2009
186
0.020
 Why?
Astrocytes
1
1990
217
0.020
 Why?
Virus Cultivation
4
1984
31
0.020
 Why?
Reoviridae
1
1988
37
0.020
 Why?
Measles
1
1989
46
0.020
 Why?
Mammalian orthoreovirus 3
1
1988
37
0.020
 Why?
Hepatitis
1
1988
45
0.020
 Why?
Disease Progression
1
2016
2793
0.020
 Why?
DNA, Recombinant
1
1988
48
0.020
 Why?
Reoviridae Infections
1
1988
55
0.020
 Why?
Cancer Vaccines
1
2009
167
0.020
 Why?
Neoplasms, Experimental
1
1969
174
0.020
 Why?
Sequence Homology, Nucleic Acid
1
1988
156
0.020
 Why?
Fetus
1
1992
802
0.020
 Why?
Health Services Needs and Demand
1
2010
286
0.020
 Why?
Cytopathogenic Effect, Viral
2
1982
16
0.020
 Why?
Microscopy, Electron
3
2001
441
0.020
 Why?
Body Fluids
1
1987
70
0.020
 Why?
Noma
1
1986
2
0.020
 Why?
Heptavalent Pneumococcal Conjugate Vaccine
1
2006
13
0.020
 Why?
Telomere
1
2010
277
0.020
 Why?
Biliary Atresia
1
1988
153
0.020
 Why?
Australia
1
2008
310
0.020
 Why?
Xenodiagnosis
1
2006
2
0.020
 Why?
Gastrointestinal Hemorrhage
1
1988
134
0.020
 Why?
Valine
1
2007
77
0.020
 Why?
Apoptosis
1
2015
2574
0.020
 Why?
Embryo, Mammalian
3
1973
236
0.020
 Why?
Interleukin-4
2
1998
215
0.020
 Why?
Amino Acid Substitution
1
2007
310
0.010
 Why?
Kidney
9
1975
1482
0.010
 Why?
Anti-Bacterial Agents
2
1999
1865
0.010
 Why?
RNA, Ribosomal
1
2006
168
0.010
 Why?
Reagent Kits, Diagnostic
1
1985
35
0.010
 Why?
Statistics as Topic
1
2006
302
0.010
 Why?
Ketones
1
1986
51
0.010
 Why?
Gene Amplification
1
2006
103
0.010
 Why?
Nectins
1
2005
6
0.010
 Why?
Mass Screening
1
2014
1310
0.010
 Why?
Residence Characteristics
1
2008
368
0.010
 Why?
Lymphoproliferative Disorders
1
1985
60
0.010
 Why?
Factor Analysis, Statistical
1
2006
296
0.010
 Why?
Carbon Isotopes
5
1973
143
0.010
 Why?
California
1
2006
462
0.010
 Why?
Streptococcus pneumoniae
1
2006
169
0.010
 Why?
Toll-Like Receptor 2
1
2005
120
0.010
 Why?
Chromosomes, Human
1
1984
44
0.010
 Why?
Cytotoxicity, Immunologic
1
1985
226
0.010
 Why?
Toll-Like Receptors
1
2005
189
0.010
 Why?
Hexuronic Acids
1
1984
23
0.010
 Why?
Glucuronic Acid
1
1984
25
0.010
 Why?
Intensive Care Units, Neonatal
1
1988
268
0.010
 Why?
Alginates
1
1984
46
0.010
 Why?
Freezing
1
1984
88
0.010
 Why?
Filtration
1
1984
70
0.010
 Why?
Polyethylene Glycols
1
1989
638
0.010
 Why?
Culture Techniques
4
1973
74
0.010
 Why?
Bone Marrow Cells
1
1984
325
0.010
 Why?
RNA, Small Interfering
1
2005
626
0.010
 Why?
Fetal Blood
1
1985
341
0.010
 Why?
Stomatitis, Herpetic
1
1982
5
0.010
 Why?
Phosphonoacetic Acid
1
1982
10
0.010
 Why?
Socioeconomic Factors
1
2007
1306
0.010
 Why?
Up-Regulation
1
2005
859
0.010
 Why?
Agammaglobulinemia
1
1982
36
0.010
 Why?
Prognosis
1
2010
4073
0.010
 Why?
Isoelectric Focusing
1
2001
30
0.010
 Why?
Rural Population
1
2006
604
0.010
 Why?
NF-kappa B
1
2005
692
0.010
 Why?
Ulnar Nerve
1
2001
17
0.010
 Why?
Interleukin-6
1
2005
792
0.010
 Why?
Temperature
1
1984
669
0.010
 Why?
Brain
1
1993
2858
0.010
 Why?
Administration, Oral
2
1997
803
0.010
 Why?
Electrophoresis, Polyacrylamide Gel
1
2001
336
0.010
 Why?
Cell Survival
1
1984
1129
0.010
 Why?
Phytohemagglutinins
1
1980
28
0.010
 Why?
Disease Models, Animal
1
1991
4405
0.010
 Why?
Serum Albumin
1
2001
153
0.010
 Why?
Ribosomes
1
2001
186
0.010
 Why?
Neuroglia
1
2001
173
0.010
 Why?
Cell Communication
1
1982
318
0.010
 Why?
Ambulatory Care
1
2004
582
0.010
 Why?
Phagocytosis
1
1982
388
0.010
 Why?
Leukocytes
1
1981
309
0.010
 Why?
Air Microbiology
1
1980
48
0.010
 Why?
Nasal Decongestants
1
1999
8
0.010
 Why?
Immunity, Maternally-Acquired
1
1979
19
0.010
 Why?
Otorhinolaryngologic Surgical Procedures
1
1999
39
0.010
 Why?
Immunoglobulins
1
1979
168
0.010
 Why?
Mitogens
1
1978
59
0.010
 Why?
Lectins
1
1978
46
0.010
 Why?
Steroids
1
1999
163
0.010
 Why?
Rabbits
1
1979
754
0.010
 Why?
Th2 Cells
1
1998
177
0.010
 Why?
Amanitins
1
1977
4
0.010
 Why?
Bronchopulmonary Dysplasia
2
1993
395
0.010
 Why?
Cross Infection
1
1980
254
0.010
 Why?
Centrifugation, Density Gradient
3
1971
40
0.010
 Why?
Antigen-Antibody Complex
1
1997
87
0.010
 Why?
Interleukin-10
1
1998
310
0.010
 Why?
Erythrocytes
1
1982
707
0.010
 Why?
Combined Modality Therapy
1
1999
1243
0.010
 Why?
Adenoviridae Infections
1
1975
19
0.010
 Why?
Patient Selection
1
1999
688
0.010
 Why?
Indicator Dilution Techniques
1
1994
12
0.010
 Why?
Uridine
2
1973
30
0.010
 Why?
Evidence-Based Medicine
1
1999
750
0.010
 Why?
Centrifugation, Zonal
2
1971
2
0.010
 Why?
Abortion, Therapeutic
1
1974
3
0.010
 Why?
Rubella virus
1
1974
9
0.010
 Why?
Heart Defects, Congenital
2
1993
875
0.010
 Why?
Cesium
2
1971
20
0.010
 Why?
Molecular Biology
2
1971
60
0.010
 Why?
Sucrose
2
1971
111
0.010
 Why?
Chlorides
2
1971
138
0.010
 Why?
Complement Fixation Tests
2
1984
6
0.010
 Why?
Hemagglutination Tests
1
1991
7
0.010
 Why?
Pulmonary Fibrosis
1
1975
400
0.010
 Why?
Genes
1
1971
229
0.010
 Why?
Population Surveillance
1
1993
481
0.000
 Why?
Stress, Psychological
1
1998
1128
0.000
 Why?
Nonoxynol
1
1989
4
0.000
 Why?
Latex
1
1989
10
0.000
 Why?
Kidney Transplantation
1
1975
675
0.000
 Why?
Ribonucleases
1
1987
48
0.000
 Why?
Suspensions
1
1987
29
0.000
 Why?
Chloroquine
1
1987
53
0.000
 Why?
Deltaretrovirus
1
1986
12
0.000
 Why?
Binding, Competitive
1
1985
196
0.000
 Why?
Leukocyte Count
1
1985
328
0.000
 Why?
Mitosis
1
1985
196
0.000
 Why?
Histocompatibility Antigens Class II
1
1985
369
0.000
 Why?
Serologic Tests
1
1983
54
0.000
 Why?
Histocompatibility Antigens
2
1974
107
0.000
 Why?
Infusions, Parenteral
1
1982
43
0.000
 Why?
Leukemia
1
1983
244
0.000
 Why?
Hospital Bed Capacity, 300 to 499
1
1980
4
0.000
 Why?
Air Movements
1
1980
10
0.000
 Why?
Liver
1
1988
1819
0.000
 Why?
Hospital Units
1
1980
32
0.000
 Why?
Boston
1
1980
91
0.000
 Why?
Communicable Disease Control
1
1980
83
0.000
 Why?
Methods
1
1978
68
0.000
 Why?
p-Fluorophenylalanine
1
1976
2
0.000
 Why?
Cycloheximide
1
1976
53
0.000
 Why?
Hospitals, Pediatric
1
1980
531
0.000
 Why?
Inclusion Bodies, Viral
1
1975
3
0.000
 Why?
Cytoplasm
1
1976
273
0.000
 Why?
Cadaver
1
1975
298
0.000
 Why?
Transplantation, Homologous
1
1975
413
0.000
 Why?
Genetic Code
1
1971
22
0.000
 Why?
Nucleic Acid Denaturation
1
1971
32
0.000
 Why?
Chymotrypsin
1
1971
23
0.000
 Why?
Platinum
1
1971
51
0.000
 Why?
Molecular Weight
1
1971
329
0.000
 Why?
DNA Replication
1
1971
240
0.000
 Why?
Carbon
1
1971
204
0.000
 Why?
Hot Temperature
1
1971
403
0.000
 Why?
Lung
1
1975
4134
0.000
 Why?
Levin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (856) concept(s)
_
Co-Authors Expand Description
See all (24) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)